Biblio Discovery — Demo Discovery Service

2 results for "Fafa Addo Boateng"

Showing 1–2 · 0.34 seconds · RSS

  1. Journal Article

    Efficacy and Safety of Long-acting Injectable Cabotegravir and Rilpivirine in Improving HIV-1 Control in sub-Saharan Africa: Protocol for a Phase 3b Open-Label Randomized Controlled Trial (IMPALA) [version 1; peer review: 2 approved]

    Fafa Addo Boateng; Daniel Grint; Eugene Ruzagira et al.

    Wellcome Open Research, Vol. 10 · 2025 · English · DOAJ Scopus

    Long-acting (LA) injectable therapy as treatment for HIV-1 infection offers reduced dosing frequency, increased discretion and provides an alternative to two or three-drug daily oral combinations. A parenteral LA formulation of cabotegravir (CAB) and rilpivirine (RPV) given by intramuscular (IM)…

  2. Journal Article

    The 96-week outcomes and pharmacokinetics of long-acting cabotegravir plus rilpivirine in South Africans

    Rosie Mngqibisa; Yashna Singh; Catherine Orrell et al.

    Southern African Journal of HIV Medicine, Vol. 26 No. 1 · 2025 · English · DOAJ Scopus

    Background: Evaluating long-term efficacy, safety and pharmacokinetics of long-acting cabotegravir + rilpivirine (CAB+RPV LA) in sub-Saharan African populations is important because of the region’s unique demographics and antiretroviral therapy resistance patterns. Objectives: To describe the…